Endo's $600M DAVA Deal Provides Case Study In Pharma M&A
Irish drugmaker Endo International PLC said Tuesday that it would expand its product pipeline by scooping up DAVA Pharmaceuticals Inc. in a deal worth up to $600 million that underscores several...To view the full article, register now.
Already a subscriber? Click here to view full article